# US 2026/0131299 A1 · Taylor reactor and capsule particle manufacturing method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0131299 A1
- Document ID: US20260131299A1
- Status: Published application
- Kind: A1
- Application number: 19/119,016
- Filed: 2023-10-17
- Published: 2026-05-14
- Earliest claimed: 2022-10-18
- Assignees: Tipton Corp.
- Applicants: Tipton Corp.
- Inventors: Takako NIWA; Koji MORITA; Tomoyuki KOBAYASHI; Kairi KATO
- Web page: https://patentgrep.com/patent/US20260131299A1

## CPC

- B01J 13/02: Making microcapsules or microballoons {(for medical preparations A61K9/50)}
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 9/1277: Preparation processes; Proliposomes
- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 9/5192: {Processes}
- A61K 31/713: Double-stranded nucleic acids or oligonucleotides
- A61K 48/0041: {the non-active part being polymeric}
- A61K 48/0091: {Purification or manufacturing processes for gene therapy compositions}
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 37/04: Immunostimulants
- B01J 13/04: by physical processes, e.g. drying, spraying
- B01J 19/1806: {resulting in a turbulent flow of the reactants, such as in centrifugal-type reactors, or having a high Reynolds-number}
- B01J 19/22: in the form of endless belts
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- C12N 2760/16134: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

An object of the present invention is to provide a capsule particle manufacturing method. A method of manufacturing a capsule particle by using a Taylor reactor is provided.

## Claims

### Claim 1

A capsule particle manufacturing method using a Taylor reactor.

### Claim 2 (depends on 1)

The manufacturing method according to claim 1, wherein
the Taylor reactor comprises an outer cylinder, an inner cylinder, and one or more inlets,
the inner cylinder is rotatably disposed in the outer cylinder and forms a reaction chamber having an annular shape between the inner cylinder and the outer cylinder, and
at least one of the inlets is disposed so as to allow a fluid to flow into the reaction chamber.

### Claim 3 (depends on 2)

The manufacturing method according to claim 2, wherein
the one or more inlets include a first inlet and a second inlet, and the first inlet and the second inlet are independent of each other and are each connected to the reaction chamber,
a particle-forming component is injected from the first inlet into the reaction chamber,
an enclosed component is injected from the second inlet into the reaction chamber, and
the inner cylinder is rotated to mix the particle-forming component and the enclosed component in the reaction chamber.

### Claim 4 (depends on 2)

The manufacturing method according to claim 2, wherein
the one or more inlets include a first line and a second line, the first line and the second line are disposed so as to merge, and a merged line is connected to the reaction chamber via a common inlet, and
a particle-forming component is injected from the first line, an enclosed component is injected from the second line, the particle-forming component and the enclosed component are mixed in front of the reaction chamber to generate a particle-forming component-enclosed component mixed liquid, then the particle-forming component-enclosed component mixed liquid is injected into the reaction chamber via the common inlet, the inner cylinder is rotated, and the particle-forming component-enclosed component mixed liquid is further mixed in the reaction chamber.

### Claim 5 (depends on 3)

The manufacturing method according to claim 3, wherein
the particle-forming component comprises a polymer component or a lipid component, and
the enclosed component comprises a nucleic acid, a protein, a polypeptide, a peptide, or a low molecular weight compound.

### Claim 6 (depends on 5)

The manufacturing method according to claim 5, wherein
the particle-forming component comprises a lipid component, and
the enclosed component comprises a nucleic acid.

### Claim 7 (depends on 3)

The manufacturing method according to claim 3, wherein the particle-forming component is injected first, and then the enclosed component is injected.

### Claim 8 (depends on 3)

The manufacturing method according to claim 3, wherein the enclosed component is injected first, and then the particle-forming component is injected.

### Claim 9 (depends on 3)

The manufacturing method according to claim 3, wherein the particle-forming component and the enclosed component are injected simultaneously.

### Claim 10 (depends on 2)

The manufacturing method according to claim 2, wherein a peripheral speed of the inner cylinder is 0.5 to 47 m/s.

### Claim 11 (depends on 2)

The manufacturing method according to claim 2, wherein a gap width between the inner cylinder and the outer cylinder is 0.01 mm to 5 mm.

### Claim 12 (depends on 1)

The manufacturing method according to claim 1, wherein a stirring time for performing a Taylor reaction is 1 minute or shorter.

### Claim 13 (depends on 3)

The manufacturing method according to claim 3, wherein a ratio of an injection rate of the particle-forming component to an injection rate of the enclosed component is a ratio selected from a range of 1:1 to 1:9.

### Claim 14 (depends on 3)

The manufacturing method according to claim 3, wherein inner diameters of the first inlet and the second inlet are the same or substantially the same.

### Claim 15 (depends on 3)

The manufacturing method according to claim 3, wherein inner diameters of the first inlet and the second inlet are different from each other.

### Claim 16

A Taylor reactor for use in a capsule particle manufacturing method, the Taylor reactor comprising an outer cylinder, an inner cylinder, and one or more inlets, wherein
the inner cylinder is rotatably disposed in the outer cylinder and forms a reaction chamber having an annular shape between the inner cylinder and the outer cylinder, and
at least one of the inlets is disposed so as to allow a fluid to flow into the reaction chamber.

### Claim 17 (depends on 16)

The reactor according to claim 16, wherein
the one or more inlets include a first inlet and a second inlet, and the first inlet and the second inlet are independent of each other and are each connected to the reaction chamber,
the first inlet is for injecting a particle-forming component,
the second inlet is for injecting an enclosed component, and
the inner cylinder is rotated for mixing the particle-forming component and the enclosed component in the reaction chamber.

### Claim 18 (depends on 16)

The reactor according to claim 16, wherein
the one or more inlets have a first line and a second line,
the first line is for injecting a particle-forming component,
the second line is for injecting an enclosed component,
the first line and the second line merge in front of the reaction chamber,
a downstream side of a merging portion forms a particle-forming component-enclosed component mixed liquid line, which is then connected to the reaction chamber via a common inlet, and
the inner cylinder is rotated for further mixing a particle-forming component-enclosed component mixed liquid in the reaction chamber.

### Claim 19 (depends on 17)

The reactor according to claim 17, wherein
the particle-forming component comprises a polymer component or a lipid component, and
the enclosed component comprises a nucleic acid, a protein, a polypeptide, a peptide, or a low molecular weight compound.

### Claim 20 (depends on 19)

The reactor according to claim 19, wherein
the particle-forming component comprises a lipid component, and
the enclosed component comprises a nucleic acid.

### Claim 21 (depends on 17)

The reactor according to claim 17, wherein, when a side on which a liquid is supplied to the reaction chamber is defined as an upstream side and a side on which the liquid is discharged from the reaction chamber is defined as a downstream side, the first inlet is disposed on the upstream side and the second inlet is disposed on the downstream side.

### Claim 22 (depends on 17)

The reactor according to claim 17, wherein, when a side on which a liquid is supplied to the reaction chamber is defined as an upstream side and a side on which the liquid is discharged from the reaction chamber is defined as a downstream side, the second inlet is disposed on the upstream side and the first inlet is disposed on the downstream side.

### Claim 23 (depends on 17)

The reactor according to claim 17, wherein the first inlet and the second inlet are disposed on the same cross section perpendicular to an axial direction of the inner cylinder.

### Claim 24 (depends on 16)

The reactor according to claim 16, wherein a gap width between the inner cylinder and the outer cylinder is 0.01 mm to 5 mm.

### Claim 25 (depends on 17)

The reactor according to claim 17, wherein a ratio of an injection rate of the particle-forming component to an injection rate of the enclosed component is a ratio selected from a range of 1:1 to 1: 9.

### Claim 26 (depends on 17)

The reactor according to claim 17, wherein inner diameters of the first inlet and the second inlet are the same or substantially the same.

### Claim 27 (depends on 17)

The reactor according to claim 17, wherein inner diameters of the first inlet and the second inlet are different from each other.
